Albany Molecular Research (AMRI) Misses Q1 EPS by 14c
Tweet
Share
E-mailGet Alerts AMRI Hot Sheet
Price: $21.74 --0%
Financial Fact:
Research and development: 4.64M
Today's EPS Names:
ZTO, AMMX, AFIB, More
Financial Fact:
Research and development: 4.64M
Today's EPS Names:
ZTO, AMMX, AFIB, More
Join SI Premium – FREE
Albany Molecular Research (NASDAQ: AMRI) reported Q1 EPS of $0.07, $0.14 worse than the analyst estimate of $0.21. Revenue for the quarter came in at $102.8 million versus the consensus estimate of $107.2 million.
Albany Molecular Research reaffirmed FY2016 guidance.
For earnings history and earnings-related data on Albany Molecular Research (AMRI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Nordson Corp. (NDSN) Tops Q3 EPS by 16c; Offers Guidance
- Webull Corp (BULL) Tops Q2 EPS by 1c
- Estee Lauder shares jump as fiscal 2027 profit forecast tops estimates
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
